Get prepared for joint clinical assessments (JCA) in Europe for your rare disease products.
RTI Health Solutions understands the complexities of generating evidence for rare diseases—from low patient numbers to lack of data and variations in standard of care—and are here to help. Our team of experts are well versed in the stringent requirements of Joint Clinical Assessment and have extensive experience collaborating with our clients throughout the product lifecycle to demonstrate the value of their rare disease product. From strategic planning to tactical delivery, we offer integrated solutions to ensure your product's success in the European market.